Strong launch for Cresemba in Japan triggers first sales milestone payment from AKP to Basilea
The achievement of the first sales milestone already in the second year of commercialization is a testament of the commercial capability of our partner AKP in this important market. The strong sales ...
PharmiWeb3 天
Lotus Pharmaceutical becomes strategic partner for…
AgreementLotus Pharmaceutical becomes strategic partner for the commercialization of Formycon’s Eylea® biosimilar FYB203/AHZANTIVE® in the Asia-Pacific Region 05.02.2025 / 06:30 CET/CESTThe issuer is ...